NVDA
NVIDIA
-- 104.020 TSLA
Tesla
-- 245.190 PLTR
Palantir
-- 79.610 AMZN
Amazon
-- 185.450 GOOG
Alphabet-C
-- 153.240 
Despite declining revenues and industry growth, Honz Pharmac...
Despite declining revenues and industry growth, Honz Pharmaceutical's P/S ratio matches the industry, hinting at a potential share price drop unless medium-term circumstances improve. Shareholders may face a tough period ahead.
Honz Pharmaceutical Co., Ltd.'s (SZSE:300086) Business Is Yet to Catch Up With Its Share Price
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment